Search
for
Sort by
Research 30 of 1000+
- Mesenchymal stem cells and their secretome: a promising approach for Parkinson’s disease treatment
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- USO DE ESTIMULAÇÃO CEREBRAL PROFUNDA (DBS) PARA O TRATAMENTO DA DOENÇA DE PARKINSON
- Enhanced delivery of drugs into and across the skin by ethosomal carriers
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases
- Parkinson's disease and skin
- Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease
- Treatment of Benign Essential Blepharospasm With Finasteride
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α‐synuclein triplication (Iowa kindred)
- ADVANCES IN FUNCTIONAL NEUROSURGERY – MACHINE LEARNING, NEURAL ENGINEERING AND ROBOTICS IN TREATMENT OF NEURODEGENERATIVE DISORDERS
- The Charnoly body as a universal biomarker of cell injury
- Factors associated with early-onset androgenetic alopecia: A scoping review
- Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Is seborrhea a sign of autonomic impairment in Parkinson's disease?
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Effets de médicaments gonadiques pour la neuroprotection du cerveau chez un modèle animal de la maladie de Parkinson
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Ability to cycle despite severe freezing of gait in atypical parkinsonism in Fahr's syndrome
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
- Biological Activities of 2,3,5,4′-Tetrahydroxystilbene-2-O-<i>β</i>-D-Glucoside in Antiaging and Antiaging-Related Disease Treatments
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson’s disease
- The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson’s disease
- Alopecia induced by dopamine agonists
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- A machine learning and network framework to discover new indications for small molecules